Company Filing History:
Years Active: 2011
Title: Jan Ploen: Innovator in Pharmaceutical Formulations
Introduction
Jan Ploen is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His innovative work focuses on enhancing the delivery and effectiveness of active ingredients in medications.
Latest Patents
Jan Ploen holds a patent for an oral dosage form for propiverine or its pharmaceutically acceptable salts. This patent describes a method for producing oral pharmaceutical compositions that contain propiverine in amounts ranging from 4 mg to 60 mg. The compositions are designed to provide a prolonged release of the active ingredient, ensuring better therapeutic outcomes for patients.
Career Highlights
Jan Ploen is associated with Apogepha Arzneimittel GmbH, where he applies his expertise in pharmaceutical formulations. His work has contributed to advancements in the field, particularly in the area of extended-release medications.
Collaborations
Jan has collaborated with notable colleagues such as Thomas Gramatte and Peter Gruber. Their combined efforts have led to innovative solutions in pharmaceutical development.
Conclusion
Jan Ploen's contributions to the pharmaceutical industry exemplify the importance of innovation in medication delivery systems. His work continues to impact the effectiveness of treatments available to patients today.